{"database": "openregs", "table": "documents", "rows": [["FDA-2013-N-1525-0016", "FDA", "FDA-2013-N-1525", "Bulk Drug Substances That May Be Used To Compound Drug Products in\nAccordance With Section 503A of the Federal Food, Drug, and Cosmetic Act; Revised Request for Nominations", "Notice", "Request for Nominations", "2014-07-02T04:00:00Z", 2014, 7, "2014-07-02T04:00:00Z", "2014-10-01T03:59:59Z", "2014-11-02T01:09:57Z", "2014-15367", 0, 0, "0900006481787042"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2013-N-1525-0016"], "units": {}, "query_ms": 82.8577260253951, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}